Ignite Creation Date:
2024-05-06 @ 7:38 PM
Last Modification Date:
2024-10-26 @ 3:11 PM
Study NCT ID:
NCT06084481
Status:
RECRUITING
Last Update Posted:
2024-07-05
First Post:
2023-10-10
Brief Title:
Study to Assess Adverse Events and Change in Disease Activity in Adult Participants With Select Advanced Solid Tumor Indications Receiving Intravenous IV ABBV-400
Sponsor:
AbbVie
Organization:
AbbVie
Key Dates - Follows AllAPIJSON File Order
Start Date:
2023-11-09
Start Date Type:
ACTUAL
Primary Completion Date:
2026-07-01
Primary Completion Date Type:
ESTIMATED
Completion Date:
2026-07-01
Completion Date Type:
ESTIMATED
First Submit Date:
2023-10-10
First Submit QC Date:
October 10 2023
Study First Post Date:
2023-10-16
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-08-26
Last Update Post Date:
2024-07-05
Last Update Post Date Type:
ACTUAL